Medelis, Inc. Alternatives & Competitors
12 companies similar to Medelis, Inc. — A specialty oncology CRO and a pioneer in immunotherapy studies.
Companies similar to Medelis, Inc.
Pune, India
4Clinics
4Clinics is now part of P95 | #DataManagement #Biostatistics #MedicalWriting #StudyManagem...
Belgium
Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
San Carlos, United States
PharPoint Research, Inc.
We're a contract research organization (CRO) that helps innovative clients meet their clin...
Durham, United States
Rival Readout
Competing with Medelis, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Imaging Endpoints
Conducting the largest and most complex trials in the industry
Scottsdale, United States
-logo.jpg "Global Clinical Trials (GCT)"){kind=logo}
Global Clinical Trials (GCT)
Global CRO, local expertise
Princeton, United States
Simbec-Orion
Flexible, high-quality, Phase I - IV clinical trial solutions, delivered with integrity.
Merthyr Tydfil, United Ki...
Alpha Cancer Technologies Inc.
HARNESSING NATURE TO BEAT CANCER
Toronto, Canada
Hammersmith Medicines Research Ltd
Specialists in clinical pharmacology, phase 1 and early phase 2 trials
Medpace
Accelerating Drug, Biologic and Medical Device Clinical Development
Cincinnati, United States
Promontory Therapeutics
Phase 2 stage biotech company developing novel small-molecule anti-cancer immunotherapies.
New York, United States
TMC Pharma Services Ltd
Your strategic partner in advancing patient health
United Kingdom
About Medelis, Inc.
Medelis, Inc. is a specialty oncology CRO that prides itself on its pioneering work in immunotherapy studies. Founded in 2003, the company has carved a niche for itself in the preclinical and phase 1 through phase 3 oncology trials in North America and Europe.
Oncology CRO, Immunotherapy, Oncology Trials, Drug Development, Clinical Operations, Preclinical Trials, Phase 1 Trials, Phase 2 Trials, Phase 3 Trials, North America, Europe, Immuno-Oncology, Medical Writing, Biostatistics
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Medelis, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Medelis, Inc. on 14 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 16 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
